ATG-018

N/A

Report date: 2022/06/07 16:24:57
NME

Base Information

Drug NameATG-018
Drug Alias NameATG-018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine-protein kinase ATR inhibitors
TargetsSerine-protein kinase ATR
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAntengene Corporation Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAntengene Corporation Co Ltd
Inactive CompaniesAntengene Discovery Ltd
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A